Hidemi Sorimachi1, Masaru Obokata1, Naoki Takahashi2, Yogesh N V Reddy1, Christopher C Jain1, Frederik H Verbrugge1,3, Katlyn E Koepp1, Sundeep Khosla4, Michael D Jensen4, Barry A Borlaug1. 1. Department of Cardiovascular Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. 2. Department of Radiology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. 3. Department of Medicine, Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, BE3500 Hasselt, Belgium. 4. Division of Endocrinology, Department of Medicine, Diabetes, Metabolism, and Nutrition, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Abstract
AIMS: Central obesity is a major risk factor for heart failure with preserved ejection fraction (HFpEF), particularly in women, but the mechanisms remain unclear. We hypothesized that sex-specific differences in visceral adipose tissue (VAT) content would differentially relate to haemodynamic severity of HFpEF in women and men. METHODS AND RESULTS: Abdominal computed tomography (CT) and invasive haemodynamic exercise testing were performed in 105 subjects with HFpEF (63 women) and 105 age-, sex-, and body mass index-matched controls. Visceral adipose tissue area was quantified by CT. As compared with control women, VAT area was 34% higher in women with HFpEF (186 ± 112 vs. 139 ± 72 cm2, P = 0.006), while VAT area was not significantly different in men with or without HFpEF (294 ± 158 vs. 252 ± 92 cm2, P = 0.1). During exercise, pulmonary capillary wedge pressure (PCWP) increased markedly and to similar extent in both men and women with HFpEF. Women with increased VAT area displayed 33% higher PCWP during exercise compared with women with normal VAT area (28 ± 10 vs. 21 ± 10 mmHg, P = 0.001), whereas exercise PCWP was similar in men with or without excess VAT (24 ± 9 vs. 25 ± 6, P = 0.89). In women, each 100 cm2 increase in VAT area was associated with a 4.0 mmHg higher PCWP (95% CI 2.1, 6.0 mmHg; P < 0.0001), but there was no such relationship in men (interaction P = 0.009). CONCLUSIONS: These data suggest that accumulation of excess VAT plays a distinct and important role in the pathophysiology of HFpEF preferentially in women. Further research is needed to better understand the mechanisms and treatment implications for visceral fat in HFpEF. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Central obesity is a major risk factor for heart failure with preserved ejection fraction (HFpEF), particularly in women, but the mechanisms remain unclear. We hypothesized that sex-specific differences in visceral adipose tissue (VAT) content would differentially relate to haemodynamic severity of HFpEF in women and men. METHODS AND RESULTS: Abdominal computed tomography (CT) and invasive haemodynamic exercise testing were performed in 105 subjects with HFpEF (63 women) and 105 age-, sex-, and body mass index-matched controls. Visceral adipose tissue area was quantified by CT. As compared with control women, VAT area was 34% higher in women with HFpEF (186 ± 112 vs. 139 ± 72 cm2, P = 0.006), while VAT area was not significantly different in men with or without HFpEF (294 ± 158 vs. 252 ± 92 cm2, P = 0.1). During exercise, pulmonary capillary wedge pressure (PCWP) increased markedly and to similar extent in both men and women with HFpEF. Women with increased VAT area displayed 33% higher PCWP during exercise compared with women with normal VAT area (28 ± 10 vs. 21 ± 10 mmHg, P = 0.001), whereas exercise PCWP was similar in men with or without excess VAT (24 ± 9 vs. 25 ± 6, P = 0.89). In women, each 100 cm2 increase in VAT area was associated with a 4.0 mmHg higher PCWP (95% CI 2.1, 6.0 mmHg; P < 0.0001), but there was no such relationship in men (interaction P = 0.009). CONCLUSIONS: These data suggest that accumulation of excess VAT plays a distinct and important role in the pathophysiology of HFpEF preferentially in women. Further research is needed to better understand the mechanisms and treatment implications for visceral fat in HFpEF. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Linda R Peterson; Pablo F Soto; Pilar Herrero; B Selma Mohammed; Michael S Avidan; Kenneth B Schechtman; Carmen Dence; Robert J Gropler Journal: JACC Cardiovasc Imaging Date: 2008-07
Authors: Dalane W Kitzman; Peter Brubaker; Timothy Morgan; Mark Haykowsky; Gregory Hundley; William E Kraus; Joel Eggebeen; Barbara J Nicklas Journal: JAMA Date: 2016-01-05 Impact factor: 56.272
Authors: Scott D Solomon; John J V McMurray; Inder S Anand; Junbo Ge; Carolyn S P Lam; Aldo P Maggioni; Felipe Martinez; Milton Packer; Marc A Pfeffer; Burkert Pieske; Margaret M Redfield; Jean L Rouleau; Dirk J van Veldhuisen; Faiez Zannad; Michael R Zile; Akshay S Desai; Brian Claggett; Pardeep S Jhund; Sergey A Boytsov; Josep Comin-Colet; John Cleland; Hans-Dirk Düngen; Eva Goncalvesova; Tzvetana Katova; Jose F Kerr Saraiva; Małgorzata Lelonek; Bela Merkely; Michele Senni; Sanjiv J Shah; Jingmin Zhou; Adel R Rizkala; Jianjian Gong; Victor C Shi; Martin P Lefkowitz Journal: N Engl J Med Date: 2019-09-01 Impact factor: 91.245
Authors: Barbara J Nicklas; Matteo Cesari; Brenda W J H Penninx; Stephen B Kritchevsky; Jingzhong Ding; Anne Newman; Dalane W Kitzman; Alka M Kanaya; Marco Pahor; Tamara B Harris Journal: J Am Geriatr Soc Date: 2006-03 Impact factor: 5.562
Authors: Nazir Savji; Wouter C Meijers; Traci M Bartz; Vijeta Bhambhani; Mary Cushman; Matthew Nayor; Jorge R Kizer; Amy Sarma; Michael J Blaha; Ron T Gansevoort; Julius M Gardin; Hans L Hillege; Fei Ji; Willem J Kop; Emily S Lau; Douglas S Lee; Ruslan Sadreyev; Wiek H van Gilst; Thomas J Wang; Markella V Zanni; Ramachandran S Vasan; Norrina B Allen; Bruce M Psaty; Pim van der Harst; Daniel Levy; Martin Larson; Sanjiv J Shah; Rudolf A de Boer; John S Gottdiener; Jennifer E Ho Journal: JACC Heart Fail Date: 2018-07-11 Impact factor: 12.035
Authors: Aaron S Eisman; Ravi V Shah; Bishnu P Dhakal; Paul P Pappagianopoulos; Luke Wooster; Cole Bailey; Thomas F Cunningham; Kathryn M Hardin; Aaron L Baggish; Jennifer E Ho; Rajeev Malhotra; Gregory D Lewis Journal: Circ Heart Fail Date: 2018-05 Impact factor: 8.790
Authors: Gabriele G Schiattarella; Pilar Alcaide; Gianluigi Condorelli; Thomas G Gillette; Stephane Heymans; Elizabeth A V Jones; Marinos Kallikourdis; Andrew Lichtman; Federica Marelli-Berg; Sanjiv Shah; Edward B Thorp; Joseph A Hill Journal: Nat Cardiovasc Res Date: 2022-03-14
Authors: Matthew J Singleton; M Benjamin Nelson; T Jake Samuel; Dalane W Kitzman; Peter Brubaker; Mark J Haykowsky; Bharathi Upadhya; Haiying Chen; Michael D Nelson Journal: J Card Fail Date: 2021-11-10 Impact factor: 6.592
Authors: Ambarish Pandey; Sanjiv J Shah; Javed Butler; Dean L Kellogg; Gregory D Lewis; Daniel E Forman; Robert J Mentz; Barry A Borlaug; Marc A Simon; Julio A Chirinos; Roger A Fielding; Elena Volpi; Anthony J A Molina; Mark J Haykowsky; Flora Sam; Bret H Goodpaster; Alain G Bertoni; Jamie N Justice; James P White; Jingzhone Ding; Scott L Hummel; Nathan K LeBrasseur; George E Taffet; Iraklis I Pipinos; Dalane Kitzman Journal: J Am Coll Cardiol Date: 2021-09-14 Impact factor: 27.203
Authors: Coenraad Withaar; Carolyn S P Lam; Gabriele G Schiattarella; Rudolf A de Boer; Laura M G Meems Journal: Eur Heart J Date: 2021-11-14 Impact factor: 29.983
Authors: Francisco J Osuna-Prieto; Borja Martinez-Tellez; Jonatan R Ruiz; Sonia Fernández-Veledo; Lourdes Ortiz-Alvarez; Xinyu Di; Lucas Jurado-Fasoli; Huiwen Xu; Victoria Ceperuelo-Mallafré; Catalina Núñez-Roa; Isabelle Kohler; Antonio Segura-Carretero; José V García-Lario; Angel Gil; Concepción M Aguilera; Jose M Llamas-Elvira; Patrick C N Rensen; Joan Vendrell Journal: Cardiovasc Diabetol Date: 2021-07-27 Impact factor: 9.951